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Abstract
Background: Brain dopamine is implicated in the regulation of movement, attention, reward and learning and plays an
important role in Parkinson’s disease, schizophrenia and drug addiction. Animal experiments have demonstrated that brain
stimulation is able to induce significant dopaminergic changes in extrastriatal areas. Given the up-growing interest of non-
invasive brain stimulation as potential tool for treatment of neurological and psychiatric disorders, it would be critical to
investigate dopaminergic functional interactions in the prefrontal cortex and more in particular the effect of dorsolateral
prefrontal cortex (DLPFC) (areas 9/46) stimulation on prefrontal dopamine (DA).
Methodology/Principal Findings: Healthy volunteers were studied with a high-affinity DA D2-receptor radioligand, [
11C]FLB
457-PET following 10 Hz repetitive transcranial magnetic stimulation (rTMS) of the left and right DLPFC. rTMS on the left
DLPFC induced a significant reduction in [
11C]FLB 457 binding potential (BP) in the ipsilateral subgenual anterior cingulate
cortex (ACC) (BA 25/12), pregenual ACC (BA 32) and medial orbitofrontal cortex (BA 11). There were no significant changes
in [
11C]FLB 457 BP following right DLPFC rTMS.
Conclusions/Significance: To our knowledge, this is the first study to provide evidence of extrastriatal DA modulation
following acute rTMS of DLPFC with its effect limited to the specific areas of medial prefrontal cortex. [
11C]FLB 457-PET
combined with rTMS may allow to explore the neurochemical functions of specific cortical neural networks and help to
identify the neurobiological effects of TMS for the treatment of different neurological and psychiatric diseases.
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Introduction
Brain dopamine (DA) is implicated in the regulation of
movement, attention, reward and learning [1–3] and plays an
important role in Parkinson’s disease, schizophrenia and drug
addiction [4–5]. Several animal and human studies have
demonstrated that the frontal cortex exerts an important influence
on striatal dopamine release both through the modulation of
dopaminergic neuronal firing [6–7] and a direct effect on nerve
terminals [8–14]. While large evidence exists on the control
exerted by the frontal cortex on striatal dopamine, very little is
known about the modulation of dopamine within the prefrontal
cortex. Animal experiments have demonstrated that brain
stimulation is able to induce significant dopaminergic changes in
extrastriatal cortical areas [10,15–18]. So far, not many studies
have been able to address this issue directly in the human brain.
Given the up-growing interest of non-invasive brain stimulation
as potential tool for treatment of neurological and psychiatric
disorders [19–21], it would be critical to investigate dopaminergic
functional interactions in the prefrontal cortex and in particular
the effect of dorsolateral prefrontal cortex (DLPFC) (areas 9/46)
stimulation on prefrontal dopamine. The DLPFC is heavily
interconnected with several cortical and subcortical areas [22–24].
In particular, anatomical and functional connections between
DLPFC and medial prefrontal cortex, including anterior cingulate
cortex (ACC) and orbitofrontal cortex, have been documented by
anatomical and neuroimaging studies [25–29].
Today, the possibility of modulating the activation of a given
cortical area in the human brain by using repetitive transcranial
magnetic stimulation (rTMS) combined with positron emission
tomography (PET) provides us with a valuable probe of brain
function to investigate neural loops in human subjects. So far,
commonly used PET radioligands (i.e. [
11C]raclopride) for
examination of DA-D2 receptors have not been useful in
providing sufficient signal-to-noise ratio in regions outside the
striatum with low D2-dopamine receptor density [30]. The
development of novel high-affinity ligands such as [
11C]FLB 457
(KD=20pM) has overcome this limitation and is enabling us to
investigate the extrastriatal dopaminergic system. These dopami-
nergic ligands have shown significant dopaminergic changes in
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34] and cognitive tasks [35–37].
In this study, we used PET ligand [
11C]FLB 457 to map and
quantify the effect of left and right DLPFC rTMS on the ipsilateral
prefrontal dopamine with the specific objectives of identifying 1)
dopaminergic changes in the ipsilateral medial prefrontal cortex
(i.e. ACC and orbitofrontal cortex) and 2) potential differences
and/or asymmetries between the two hemispheres.
Results
Parametric image analysis revealed significant differences
between left and right hemisphere. Table 1 summarizes the main
findings. rTMS on the left DLPFC induced a specific reduction in
[
11C]FLB 457 binding potential (BP) in the ipsilateral subgenual
ACC (BA 25/12), pregenual ACC (BA 32) and medial
orbitofrontal gyrus (BA 11), likely reflecting dopamine release in
those areas (Figure 1). There was no statistically significant BP
difference in any other cortical areas. The same stimulation
paradigm applied over the right DLPFC did not induce any
detectable changes in [
11C]FLB 457 BP in the medial prefrontal
cortex or other cortical regions.
Individual BPs extracted from ROI centered at the statistical
peak defined by the parametric maps (subgenual ACC: x=210,
y=28, z=218; pregenual ACC: x=214, y=40, z=210;
medial orbitofrontal cortex: x=26, y=30, z=220) confirmed
these findings and showed significant BP reduction following left
but not right DLPFC rTMS (Table 2 and Figure 2). Repeated-
measures ANOVA revealed a significant interaction between
rTMS site (left2right DLPFC)6ROI site (left2right ROI) in the
subgenual ACC (F(1, 6)=15.01, P=0.008), the pregenual ACC
(F(1, 6)=155.64, P=0.00002) and orbitofrontal gyrus (F(1,
6)=6.64, P=0.04).
The post-hoc paired t-test confirmed a significant reduction in
[
11C]FLB 457 BP compare to control condition following left
DLPFC rTMS in the ipsilateral the subgenual ACC (mean6SD:
0.9360.28 vs 0.5960.24; t=11.2, P,0.001), pregenual ACC
(mean6SD: 0.6760.24 vs 0.3860.22; t=8.4, P,0.001) and
medial orbitofrontal cortex (mean6SD: 0.9060.27 vs 0.6960.24;
t=9.1, P,0.001). The mean magnitude of decrease in [
11C]FLB
457 BP was 237.769.7% for subgenual ACC, 245.3617.1% for
pregenual ACC, and 223.667.4% for medial orbitofrontal
cortex. In contrast, no significant BP changes were seen following
stimulation of the right DLPFC compared to the control condition
in the right subgenual ACC (x=10, y=28, z=218, 0.7460.21 vs
0.7660.30, t=0.2, N.S), right the pregenual ACC (x=14, y=40,
z=210, 0.3460.12 vs 0.3860.12, t=1.1, N.S), and right medial
orbitofrontal cortex (x=6, y=30, z=220, 0.6360.22 vs
0.6560.15, t=0.20, N.S) (Table 2 and Figure 2).
To rule out a potential behavioral contribution to these findings,
behavioral ratings before and after left or right DLPFC rTMS
were measured and results are presented in Table 3. Statistical
analysis of behavioral measures revealed no significant main effect
of the stimulation site (left or right DLPFC rTMS) and rTMS
condition (before and after rTMS) and interaction in all behavioral
aspect.
Table 1. Prefrontal regions with reduction in [
11C]FLB 457 BP following left DLPFC stimulation.
Region BA coordinates* x, y, z z-score SVC corrected-P value Cluster size (mm
3)
L subgenual ACC BA 25/12 210, 28, 218 4.40 0.003 1432
L medial OFC BA 11 26, 30, 220 3.89 0.025 424
L pregenual ACC BA 32 214, 40, 210 4.15 0.008 1024
L: left, ACC: anterior cingulated cortex, OFC: orbitofrontal cortex, BA: Brodmann’s area *Talairach coordinate (mm), SVC: small volume correction.
doi:10.1371/journal.pone.0006725.t001
Figure 1. Sagittal and transverse sections of the statistical parametric map of the changes in [
11C]FLB 457 BP after left DLPFC
stimulation overlaid upon the standard MRI.
doi:10.1371/journal.pone.0006725.g001
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11C]FLB 457 BP changes in prefrontal regions following left and right DLPFC.
Left DLPFC rTMS control P Right DLPFC rTMS control P
subgenual ACC 0.93 (0.28) 0.59 (0.24) ,0.001* 0.74 (0.21) 0.76 (0.30) 0.9
pregenual ACC 0.67 (0.24) 0.38 (0.22) ,0.001* 0.34 (0.12) 0.38 (0.12) 0.3
medial OFC 0.90 (0.27) 0.69 (0.24) ,0.001* 0.63 (0.22) 0.65 (0.15) 0.9
ACC: anterior cingulated cortex, OFC: orbitofrontal cortex, DLPFC: dorsolateral prefrontal cortex, Number in brackets indicates S.D.
*Bonferroni correction.
doi:10.1371/journal.pone.0006725.t002
Figure 2. Individual mean BPs extracted from 10 mm radius VOI. Upper, middle and lower figures show the individual [
11C]FLB 457 BP
changes the subgenual ACC (x=210, y=28, z=218), pregenual ACC (x=214, y=40, z=210) and medial orbitofrontal cortex (x=26, y=30,
z=220) under control and active rTMS conditions, respectively.
doi:10.1371/journal.pone.0006725.g002
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The present rTMS/[
11C]FLB 457 PET study revealed two
main findings. First, that DLPFC-rTMS led to focal DA changes
in the ipsilateral ACC (subgenual part, BA 25/12 and pregenual
part, BA 32) and medial orbitofrontal cortex (BA 11) and second,
that while stimulation paradigm and target cortical area were
similar among all subjects, only left DLPFC but nor right DLPFC
induced significant changes in [
11C]FLB 457 BP in those areas.
Previous PET studies, have shown that [
11C]FLB 457 BP may
provide a reasonable estimate of receptor densities in different
extrastriatal areas including cingulate cortex [38] and may be
sensitive in detecting changes in extrastriatal endogenous dopa-
mine concentration [31,34,35,39,40]. PET animal experiments in
baboon monkeys with [
18F]fallypride (a similar high-affinity
dopaminergic radioligand) have confirmed these findings and
showed that amphetamine challenge may induce a striking
reduction in BP in the ACC (41%) and other extrastriatal areas
[41]. Thus, there is large evidence that [
11C]FLB 457 ligand may
be well-suited to capture differences in dopaminergic binding in
prefrontal areas.
Recently, the medial prefrontal areas including ACC and
orbitofrontal cortex have received particular attention in cognitive
and behavioral brain imaging studies. The ACC in particular has
emerged as a locus of information processing and regulation [42].
In terms of cytoarchitecture, the ACC is a heterogeneous area in
its functions and connectivity [27,43]. It is involved in motor
control, cognition, pain and emotion, arousal and drive [44]. In
humans, this brain structure can be divided into caudal and rostral
along the vertical plain (Y=10) and supracallosal and subcallosal
runs along the horizontal plain (Z=2). Particularly, the subcallosal
part of the ACC (including pre and subgenual ACC) is linked with
DLPFC and orbitofrontal cortex as well as striatal area [27,42].
This is associated with non-goal directed, stimulus independent
processes included within the default mode network comprising
the ventromedial prefrontal, posterior cingulate and lateral
parietal cortex [45,46].
The ACC is one of the main target areas of the mesocortical
dopamine system originating in the ventral tegmental area (VTA)
[1,47]. The prefrontal cortex sends glutamate containing projec-
tion to the VTA in the midbrain influencing the mesocortical
ascending dopaminergic pathway [48–50]. In particular, Taber
and his co-worker found that the glutamatergic projection from
prefrontal cortex regulates the activation of dopaminergic neuron
in VTA [50]. Thus, it is possible that stimulation of the left
prefrontal cortex with rTMS and subsequent activation of VTA
via glutamatergic projection can possibly influence VTA dopami-
nergic neurons and cause dopaminergic changes in ACC/medial
orbitofrontal area.
However, it cannot be ruled out a more direct rTMS-induced
effect of DLPFC on ACC and orbitofrontal cortex. In fact,
because of the dense anatomical connections between DLPFC and
ACC [25–27], we cannot exclude the possibility that these effects
might be mediated by local activation of the nerve terminals. It is
interesting to note on this purpose one study done in treatment-
resistant depressed patient which demonstrated specific functional
interaction between DLPFC and subgenual ACC where deep
brain stimulators (DBS) were implanted. In these patients,
Mayberg and colleagues showed that DBS of subgenual ACC
(in the same location where also our findings were observed) was
able to restore activation of the DLPFC showing evidence of a
strong functional interaction between these two prefrontal areas
[29].
A striking observation of our study was the asymmetric effect on
dopamine release between left and right hemisphere. It is known
that the rCBF changes induced by prefrontal rTMS differ upon
hemisphere stimulated and vary with stimulation frequency [51].
Hemispheric differences of the frontal lobe in anatomy and
neurochemistry as well as in cognition and behavior are well
described and not unknown in the literature [52]. In fact,
differences in laterality involving DLPFC has been shown in
several cognitive domains such as inhibition [53], time perception
[54] and risk taking behavior [55]. In a recent rTMS/
[
11C]raclopride PET during set-shifting task, our group found a
significant hemispheric asymmetry [56]. rTMS of the left DLPFC
impaired executive task performance and dopamine release in the
ipsilateral striatum while no effects were seen following right
DLPFC stimulation. Differences in left and right hemispheric
involvement of TMS treatment in patients with depression have
also been reported [57,58]. In a recent review on the efficacy of
rTMS in major depression, the large majority of those studies
reported significant remission of depression following high-
frequency rTMS applied to the left DLPFC [59] while some
changes with right DLPFC were seen only when different and
lower stimulation frequencies (i.e. 1 Hz) were used. These
observations were re-confirmed in another large double-blinded,
multisite study, with major depression patients who were
randomized to high-frequency rTMS (at 10 Hz) or sham TMS
over the left DLPFC and found that active rTMS was effective in
treating major depression [60]. Possibly, different neuroanatom-
ical and neurochemical modulations are involved in the left and
right prefrontal neural networks to explain such differences in
cognition and behavior. On this note, it would be worth to report
previous studies showing that left and right 6-hydroxydopamine
lesions of the medial prefrontal cortex differentially alter
subcortical dopamine utilization and the behavioral response to
stress [61]. These important experiments revealed that an intrinsic
asymmetry in brain dopaminergic systems interacts with left and
Table 3. Mean behavioral ratings before and after rTMS of the left and right DLPFC.
Pre Left DLPFC rTMS Post Left DLPFC rTMS P Pre Right DLPFC rTMS Post Right DLPFC rTMS P
Discomfort-comfort 1.29 (1.89) 0.43 (1.90) N.S 1.57 (0.79) 0.43 (1.51) N.S
Fatigued-rested 20.14 (1.57) 20.29 (1.80) N.S 20.43 (1.27) 0.71 (1.11) N.S
Anxious-calm 20.14 (1.86) 0.14 (2.04) N.S 0.43 (1.13) 0.43 (1.62) N.S
Sad-happy 1.29 (1.11) 1.43 (0.79) N.S 1.14 (1.46) 1.43 (1.13) N.S
Irritated-soothed 20.43 (1.90) 0.57 (1.27) N.S 20.29 (1.89) 0.29 (1.38) N.S
Feel pain-do not feel pain 20.14 (2.27) 0.57 (1.13) N.S 20.29 (2.06) 20.43 (0.98) N.S
DLPFC: dorsolateral prefrontal cortex, Number in brackets indicates S.D.
doi:10.1371/journal.pone.0006725.t003
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nergic function and behavior that it subserves.
Whether our observation of an asymmetric rTMS-induced
release of dopamine in specific medial prefrontal areas may be
associated with the different modulatory effect on executive
performance and behavior reported in previous TMS reports
cannot be established in the current study because our subjects
were healthy controls, completely at rest and not engaging in any
form of task. In addition, to rule out potential confounding factors
to our findings, behavioral ratings before and after the left or right
DLPFC rTMS were measured and statistical analysis did not
reveal any significant effect in different behavioral aspect.
In the interpretation of our results, we should also keep in mind
that methodological factors may have prevented to detected
dopaminergic changes in other cortical areas. In fact, neurochem-
ically, the medial prefrontal cortex (in particular the ACC) is an
area with dense DA receptor concentration [38,62]. Post-mortem
human brain studies with [
125I]epidepride have shown that
concentration of dopamine receptor in different cortical areas is
considerably lower than in the ACC [62] and pharmacological
challenges (methylphenidate, amphetamine, alfentanil) during
PET using high-affinity dopaminergic ligands have confirmed
these observations revealing detectable changes in cortical
dopamine mainly in cingulate cortex [34,40,41]. Thus, in light
of these reports, we should not exclude the possibility that low
concentration of dopamine receptor may have prevented to detect
reliable and significant radioactive signal in other cortical areas
such as the DLPFC.
It is well known that dopamine can be released via two main
different mechanisms [63,64]: (1) transient or phasic dopamine
release caused by dopaminergic neuronal firing and (2) sustained
tonic dopamine release regulated by glutamatergic inputs on
dopaminergic terminals. Grace has suggested that phasic dopa-
mine release consists of large amplitude, transient increase of
synaptic dopamine which is rapidly removed from the synaptic
cleft by re-uptake. In contrast, extrasynaptic tonic dopamine
release occurs slowly with a prolonged onset, delayed peak and
extended duration [63,64]. The entire process occurs over periods
of tens of minutes to hours. It is possible that, given the
methodological approach used in our study, the [
11C]FLB 457
PET technique is most sensitive to extra-synaptic tonic dopamine
release. Given the important role of dopamine in placebo and the
potential implication of rTMS use on treatment, it would be
natural to ask whether our findings could be explained by an effect
of placebo. We believe that this is not case for several reasons.
First, while placebo does well apply to a patient population where
the expectation of clinical benefit does in fact play a major role
[65], this does not have the same impact on healthy normal
subjects where there is not expectation of improvement or clinical
benefit. In addition, our healthy subjects were naı ¨ve to TMS and
its role as potential tool for treatment. Second, the release of
dopamine observed in our study was quite focal (limited to few
specific regions) and seen only following left but not right DLPFC
stimulation. This would not be the case if placebo would play a
role where a more diffuse effect [66] and no difference in laterality
would be observed. Third, no differences were observed in our
studies on behavioral measures between the left and right
stimulation. For all these reasons, we consider quite unlikely a
potential role of placebo.
To our knowledge, this is the first study to provide evidence of
extrastriatal DA modulation following acute rTMS of the DLPFC
with its effect limited to the medial part of prefrontal cortex
including pregenual, subgenual ACC and medial orbitofrontal
cortex. PET imaging studies with dopaminergic high-affinity
ligands combined with rTMS are a promising method for
exploring specific cortical neural networks and their functional
connectivity. Studies of neurochemical functions with rTMS may
be useful for exploring hemispheric differences and the effects of
these differences on striatal and extrastriatal dopaminergic system.
This may help to better delineate the neurobiological effects of
rTMS for the treatment of different neurological and psychiatric
diseases.
Materials and Methods
Subjects and design
Seven right-handed young (2 females: 5 males; age, 23.365.6
years) healthy subjects were enrolled in this study. Exclusion
criteria included history of psychiatric and/or neurological
disorder (particularly epilepsy), any previous exposure to stimulant
drugs, pregnancy and migraine. To rule out structural lesions in
the brain and to provide anatomical reference for the analysis, T1-
weighted high resolution MRI image (GE Signa 1.5 T, T1-
weighted images, 1 mm slice thickness) where obtained for each
subject. Written informed consent was obtained in all cases before
study enrollment. The study protocols were approved by the
Ethical Committee of the Center for Addiction and Mental Health
Research, University of Toronto. Each subject underwent two
PET scans performed on separate days. On one day, the subject
received right DLPFC stimulation; on the other day, the subject
received left DLPFC. The two sessions were counterbalanced.
Behavioral ratings were collected before and after the rTMS
during each PET session.
rTMS
The rTMS procedure and target area (left/right DLPFC: [x, y,
z]=[2/+40, 32, 30]) were similar to those used in our previous
studies [11]. Biphasic high-frequency rTMS was carried out with
the Magstim Rapid
2 magnetic stimulator (Magstim, UK), using a
figure-of-eight focal coil (70-mm diameter). The target area was
localized on the individual MRI using the frameless stereotaxic
system (Brainsight
TM, Montreal, Canada). The TMS coil was held
in the scanner in a fixed position by a mechanical arm over the
target area and positioning was monitored under real-time
guidance using the neuronavigation system. The coil was oriented
so that the induced-electric current flowed in a posterior-anterior
direction which has been considered to be more effective in
activating underlying cortical neurons [67]. Five rTMS blocks
were delivered, each block separated by a 5-minute interval. In
each block, 15 trains of 1-sec duration were delivered at a
stimulation frequency of 10 Hz, with a between-train interval of
10 sec. Thus, a total of 750 stimuli were delivered over about 30
minutes preceding the start of the PET acquisition (Figure 3).
Stimulus intensity, expressed as a percentage of the maximum
stimulator output, was set at 100% of the resting motor threshold
for the contralateral first dorsal interosseous (FDI) muscle. Motor
threshold was defined according to current guidelines [68], as the
lowest stimulus intensity able to elicit 5 motor evoked potentials of
at least 50 uV amplitude in a series of 10 stimuli delivered over the
motor cortex at intervals longer than 5 seconds.
PET Imaging
PET scans were obtained with a high resolution PET CT,
Siemens-Biograph HiRez XVI (Siemens Molecular Imaging,
Knoxville, TN, U.S.A.) operating in 3D mode with an in-plane
resolution of approximately 4.6 mm full width at half-maximum.
To minimize subject’s head movements in the PET scanner, we
used a custom-made thermoplastic facemask together with a
rTMS and Prefrontal Dopamine
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the acquisition of a scout view for accurate positioning of the
subject, a low dose (0.2 mSv) CT scan for attenuation correction
was conducted before the rTMS session. Within 5 minutes of the
completion of the rTMS, 10mCi of [
11C]FLB 457 were injected
into the left antecubital vein over 60 seconds and 31 frames of
dynamic scanning were acquired over 90 min [30]. For each 3D
sinogram, data were normalized with attenuation and scatter
corrected before applying fourier rebinning to convert the 3D
sinograms into 2D sinograms. The 2D sinograms were then
reconstructed into image space using a 2D filtered back pro-
jection algorithm, with a ramp filter at Nyquist cut-off frequency.
After reconstruction a gaussian filter with a 5 mm FWHM was
applied and the images calibrated to nCi/cc. The spatial
resolution of the reconstructed images was 1.0661.0662m m
(X6Y6Z).
Image analysis
After the realignment procedure for motion correction among
the frames, motion corrected PET frames were summed, co-
registered to the corresponding individual MRI and transformed
into standardized stereotaxic space. The BP map in each subjects
was generated by Pmod 2.9 (Pmod Technologies Ltd., Switzer-
land), based on the simplified reference model [69,70] using the
ipsilateral cerebellum of the stimulated hemisphere as a reference
region. According to our previous studies [11,12,66], the effect of
rTMS on dopamine release is strictly limited to the ipsilateral
hemisphere thus changes in extrastriatal DA BP of the stimulated
hemisphere were tested against [
11C]FLB 457 BP of the
ipsilateral (non-stimulated) hemisphere of the other session
(control) (Figure 4). The image preprocessing and statistical
analysis were done with SPM 2 (Wellcome Department of
Imaging Neuroscience, London). Statistical maps were thre-
s h o l d e da tal e v e lo fP,0.001 uncorrected with an extent
threshold of at least 20 contiguous voxels [71]. Regions were
considered significant at the threshold of P-value,0.05 corrected
at the cluster level (z score.3.10). In the regions defined in our a
priori hypothesis we performed a spherical volume correction
(SVC radius 10 mm) and results were considered significant at
cluster-based (family wise error - FWE) corrected P-value,0.05.
A priori prefrontal areas were defined using the Brodmann’s
areas (BA 9/46, BA 24/25/32, BA 11) included in WFU_Pick-
Atlas (SPM extension toolbox). To confirm individual changes in
binding, BPs were extracted from regions of interest (ROI,
radius=10 mm) centered at the statistical peak defined by the
parametric maps and a statisticala n a l y s i sw a sp e r f o r m e dw i t h
within-subject repeated-measures analysis of variance (ANOVA)
with a 2 (rTMS site: left and right DLPFC rTMS)62( R O Is i t e :
left and right ROI) design for each of the three ROIs. A 2-tailed
paired t-test (with Bonferroni corrections) was performed as post-
hoc analysis to confirm the differences in BPs between rTMS and
control condition for each ROI. Statistical analyses were
performed with SPSS 13.0 software (SPSS Inc., Chicago,
Illinois).
Behavioral rating
Subjects completed behavioral questionnaires in which they
rated the level of their comfort, fatigue, anxiety, mood, irritation
and pain before and after each rTMS sessions. Ratings were made
on a seven-point Likert scale ranging from 23 to 3, with 23
indicating the highest negative level and 3 indicating the highest
positive level for each dimension.
Figure 4. Contrast analysis for each stimulation conditions:
changes in [11C]FLB 457 BP of the stimulated hemisphere were
tested against [11C]FLB 457 BP of the ipsilateral (non-
stimulated) hemisphere of the other session (control). Red
mark indicate stimulation site.
doi:10.1371/journal.pone.0006725.g004
Figure 3. Timeline of the experimental setup for rTMS and [
11C]FLB 457 PET imaging.
doi:10.1371/journal.pone.0006725.g003
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